BVF PARTNERS L P/IL Insider Trading $INFI INFINITY PHARMACEUTICALS, INC.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 5,663,912 shares
Current Value: $13,310,193
Latest Transaction: Jan 26 2021
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in INFINITY PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 568,019 | 2,350,917 | 686,974 | 1.3 M to 687 K (-45.26 %) |
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 2,458,838 | 10,176,639 | 4,172,298 | 6.6 M to 4.2 M (-37.08 %) |
Jan 26 2021 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.14 | 2,821,663 | 11,678,299 | 5,663,912 | 8.5 M to 5.7 M (-33.25 %) |
Dec 17 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.20 | 120,539 | 144,587 | 6,631,136 | 6.5 M to 6.6 M (+1.85 %) |
Dec 17 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.20 | 54,461 | 65,326 | 8,485,575 | 8.4 M to 8.5 M (+0.65 %) |
Nov 30 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.30 | 100,000 | 130,000 | 6,510,597 | 6.4 M to 6.5 M (+1.56 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 581 | 784 | 1,254,993 | 1.3 M to 1.3 M (+0.05 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 4,119 | 5,561 | 8,431,114 | 8.4 M to 8.4 M (+0.05 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 5,573 | 7,524 | 1,254,412 | 1.2 M to 1.3 M (+0.45 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 38,001 | 51,301 | 6,410,597 | 6.4 M to 6.4 M (+0.60 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 50,044 | 67,559 | 8,426,995 | 8.4 M to 8.4 M (+0.60 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 81,648 | 111,841 | 1,248,839 | 1.2 M to 1.2 M (+7.00 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 556,709 | 762,580 | 6,372,596 | 5.8 M to 6.4 M (+9.57 %) |
Nov 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.37 | 733,151 | 1,004,270 | 8,376,951 | 7.6 M to 8.4 M (+9.59 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 39,074 | 52,750 | 5,815,887 | 5.8 M to 5.8 M (+0.68 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 52,400 | 70,740 | 7,643,800 | 7.6 M to 7.6 M (+0.69 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 92,960 | 124,566 | 5,776,813 | 5.7 M to 5.8 M (+1.64 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 117,290 | 157,169 | 7,591,400 | 7.5 M to 7.6 M (+1.57 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 562,754 | 759,718 | 5,683,853 | 5.1 M to 5.7 M (+10.99 %) |
Nov 15 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 41,454 | 55,963 | 7,474,110 | 7.4 M to 7.5 M (+0.56 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 36,825 | 60,761 | 1,167,191 | 1.1 M to 1.2 M (+3.26 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 158,151 | 260,949 | 5,121,099 | 5 M to 5.1 M (+3.19 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 230,555 | 380,416 | 7,432,656 | 7.2 M to 7.4 M (+3.20 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 179,893 | 296,823 | 1,130,366 | 950.5 K to 1.1 M (+18.93 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 1,419,907 | 2,342,847 | 4,962,948 | 3.5 M to 5 M (+40.08 %) |
Jun 21 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.65 | 1,916,760 | 3,162,654 | 7,202,101 | 5.3 M to 7.2 M (+36.27 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 97,453 | 194,906 | 950,473 | 853 K to 950.5 K (+11.42 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 365,682 | 731,364 | 3,543,041 | 3.2 M to 3.5 M (+11.51 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 2.00 | 546,865 | 1,093,730 | 5,285,341 | 4.7 M to 5.3 M (+11.54 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 62,437 | 118,630 | 853,020 | 790.6 K to 853 K (+7.90 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 208,872 | 396,857 | 3,177,359 | 3 M to 3.2 M (+7.04 %) |
Apr 11 2018 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.90 | 228,691 | 434,513 | 4,738,476 | 4.5 M to 4.7 M (+5.07 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 63,042 | 80,946 | 790,583 | 727.5 K to 790.6 K (+8.67 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 235,326 | 302,159 | 2,968,487 | 2.7 M to 3 M (+8.61 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 355,081 | 455,924 | 4,509,785 | 4.2 M to 4.5 M (+8.55 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 28,918 | 35,714 | 727,541 | 698.6 K to 727.5 K (+4.14 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 394,078 | 486,686 | 2,733,161 | 2.3 M to 2.7 M (+16.85 %) |
Oct 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.24 | 523,601 | 646,647 | 4,154,704 | 3.6 M to 4.2 M (+14.42 %) |
Jan 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 3,234 | 4,333 | 2,339,083 | 2.3 M to 2.3 M (+0.14 %) |
Jan 05 2017 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 1,145 | 1,534 | 3,631,103 | 3.6 M to 3.6 M (+0.03 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 1,205 | 1,614 | 2,335,849 | 2.3 M to 2.3 M (+0.05 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 2,348 | 3,145 | 3,629,958 | 3.6 M to 3.6 M (+0.06 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 77,076 | 102,943 | 698,623 | 621.5 K to 698.6 K (+12.40 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 260,046 | 347,317 | 2,334,644 | 2.1 M to 2.3 M (+12.53 %) |
Dec 30 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.34 | 401,726 | 536,545 | 3,627,610 | 3.2 M to 3.6 M (+12.45 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 2,244 | 3,040 | 621,547 | 619.3 K to 621.5 K (+0.36 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 8,111 | 10,990 | 2,074,598 | 2.1 M to 2.1 M (+0.39 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.35 | 11,646 | 15,779 | 3,225,884 | 3.2 M to 3.2 M (+0.36 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 21,021 | 28,555 | 619,303 | 598.3 K to 619.3 K (+3.51 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 69,041 | 93,785 | 2,066,487 | 2 M to 2.1 M (+3.46 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.36 | 108,202 | 146,982 | 3,214,238 | 3.1 M to 3.2 M (+3.48 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 47,812 | 61,199 | 598,282 | 550.5 K to 598.3 K (+8.69 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 150,451 | 192,577 | 1,997,446 | 1.8 M to 2 M (+8.15 %) |
Dec 20 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.28 | 236,393 | 302,583 | 3,106,036 | 2.9 M to 3.1 M (+8.24 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 2,916 | 3,470 | 550,470 | 547.6 K to 550.5 K (+0.53 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 18,586 | 22,119 | 1,846,995 | 1.8 M to 1.8 M (+1.02 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.19 | 30,998 | 36,891 | 2,869,643 | 2.8 M to 2.9 M (+1.09 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 15,161 | 17,958 | 547,554 | 532.4 K to 547.6 K (+2.85 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 52,457 | 62,135 | 1,828,409 | 1.8 M to 1.8 M (+2.95 %) |
Dec 02 2016 | INFI | INFINITY PHARMACEU ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.18 | 81,276 | 96,271 | 2,838,645 | 2.8 M to 2.8 M (+2.95 %) |
Page: 1